Filter

131-140 of 380 results

  • The COVAX Humanitarian Buffer for COVID-19 Vaccines: Review and Assessment of Policy Implications

    Issue Brief

    In this Issue Brief we review and assess the COVAX Humanitarian Buffer mechanism, which is part of the effort to share Covid vaccines globally. The Buffer is intended to direct vaccines to vulnerable people like refugees and others facing humanitarian emergencies during the pandemic, and was supported by the US and many other donors and organizations. However, it faced many challenges such as liability and indemnification issues for using newly developed vaccines, restricted access to…

  • How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?

    Issue Brief

    This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.

  • FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment

    Issue Brief

    These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries, including questions related to out-of-pocket costs, the COVID-19 vaccine, telehealth, extended supplies of medication, skilled nursing facility stays, and issues for people in private Medicare Advantage plans.

  • Supply vs Demand: Which States are Reaching their COVID-19 Vaccine Tipping Points?

    Policy Watch

    This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

  • New Campaign from THE CONVERSATION / LA CONVERSACIÓN Responds to Information Needs about COVID-19 Vaccines Among Latinos and Spanish-speaking People in U.S.

    News Release

    News Release May 20, 2021 – THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines in the Latinx community with new videos featuring doctors, nurses and promotoras (community health workers) in English and Spanish. This installment of the campaign is produced by KFF (Kaiser Family Foundation) under its Greater Than COVID public information response and presented with UnidosUS. “THE CONVERSATION / LA CONVERSACIÓN campaign—and our efforts with the UnidosUS Esperanza Hope for…

  • Putting U.S. Global COVID-19 Vaccine Donations in Context

    Policy Watch

    While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country.  In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.

  • Falsehoods About Transgender People and Gender Affirming Care — The Monitor

    Feature

    This volume explores politically motivated misinformation targeting gender-affirming care, transgender people, and its impact on online discourse, legislation, and health care access. We also examine Florida Surgeon General Ladapo's recent misleading claims about mRNA vaccines and new technology that can predict if social media users will share disinformation.

  • Better Prompting May Help Reduce AI Hallucinations, False Vaccine Claims Spread, and Industrial Solvent Promoted as Hidden Cancer Cure — The Monitor

    Feature

    This volume examines how prompting techniques can reduce incorrect medical information from AI chatbots; false claims linking vaccines to sudden infant death syndrome; the promotion of an industrial solvent as an allegedly suppressed cancer cure; misunderstandings about the risks of overdose from fentanyl exposure; and ongoing myths about sunscreen safety.

  • Omicron Variant Increases Worries and Gives Momentum to COVID-19 Booster Shots; May Motivate a Small Share of Unvaccinated Adults to Get an Initial Shot

    News Release

    The emergence of the omicron COVID-19 variant is encouraging many already vaccinated adults to get a recommended booster shot but is providing only a little motivation for unvaccinated adults to get an initial shot, a new KFF COVID-19 Vaccine Monitor quick response survey finds. Fielded from Dec. 15-20 to provide an early look at omicron’s potential impact on the public’s vaccination intentions, the survey finds that about half (54%) of vaccinated adults who haven’t gotten…